Leblond, David
902  results:
Search for persons X
?
1

Stability analysis using mixed models: A critique of tolera..:

Altan, Stan ; Faya, Paul ; Rauk, Adam P....
Pharmaceutical Statistics.  22 (2023)  5 - p. 784-796 , 2023
 
?
3

Survey and Recommendations on the Use ofP-Values Driving De..:

Altan, Stan ; Amaratunga, Dhammika ; Cabrera, Javier...
Statistics in Biopharmaceutical Research.  15 (2022)  2 - p. 343-358 , 2022
 
?
4

Bayesian statistical approaches to drug product variability..:

Cai, Qing ; Mockus, Linas ; LeBlond, David...
International Journal of Pharmaceutics.  624 (2022)  - p. 122037 , 2022
 
?
5

Risk-Based Approach to Lot Release:

Mockus, Linas ; Reklaitis, Gintaras ; Morris, Kenneth.
Journal of Pharmaceutical Sciences.  109 (2020)  2 - p. 1035-1042 , 2020
 
?
10

AICc for Calibration Model Selection in Assay Validation:

Zhang, Lanju ; Tan, Charles ; LeBlond, David
Statistics in Biopharmaceutical Research.  9 (2017)  4 - p. 379-383 , 2017
 
?
11

Testing Assay Linearity Over a Pre-Specified Range:

Yang, Harry ; Novick, Steven J. ; LeBlond, David
Journal of Biopharmaceutical Statistics.  25 (2014)  2 - p. 339-350 , 2014
 
?
12

The Posterior Probability of Passing a Compendial Standard,..:

LeBlond, David ; Mockus, Linas
Statistics in Biopharmaceutical Research.  6 (2014)  3 - p. 270-286 , 2014
 
?
14

The Relationship between Different Assays for Detection and..:

Ellis, Teresa A. ; Li, Jinhe ; LeBlond, David.
International Journal of Alzheimer's Disease.  2012 (2012)  - p. 1-3 , 2012
 
1-15